158 related articles for article (PubMed ID: 18383466)
1. Phosphorylation by sphingosine kinase 2 is essential for in vivo potency of FTY720 analogues.
Högenauer K; Billich A; Pally C; Streiff M; Wagner T; Welzenbach K; Nussbaumer P
ChemMedChem; 2008 Jul; 3(7):1027-9. PubMed ID: 18383466
[No Abstract] [Full Text] [Related]
2. NBD-labeled derivatives of the immunomodulatory drug FTY720 as tools for metabolism and mode of action studies.
Ettmayer P; Baumruker T; Guerini D; Mechtcheriakova D; Nussbaumer P; Streiff MB; Billich A
Bioorg Med Chem Lett; 2006 Jan; 16(1):84-7. PubMed ID: 16236505
[TBL] [Abstract][Full Text] [Related]
3. S1P receptor mediated activity of FTY720 phosphate mimics.
Högenauer K; Hinterding K; Nussbaumer P
Bioorg Med Chem Lett; 2010 Mar; 20(5):1485-7. PubMed ID: 20153186
[TBL] [Abstract][Full Text] [Related]
4. Expression of sphingosine kinase 2 in synovial fibroblasts of rheumatoid arthritis contributing to apoptosis by a sphingosine analogue, FTY720.
Kamada K; Arita N; Tsubaki T; Takubo N; Fujino T; Soga Y; Miyazaki T; Yamamoto H; Nose M
Pathol Int; 2009 Jun; 59(6):382-9. PubMed ID: 19490468
[TBL] [Abstract][Full Text] [Related]
5. FTY720 (fingolimod) sensitizes prostate cancer cells to radiotherapy by inhibition of sphingosine kinase-1.
Pchejetski D; Bohler T; Brizuela L; Sauer L; Doumerc N; Golzio M; Salunkhe V; Teissié J; Malavaud B; Waxman J; Cuvillier O
Cancer Res; 2010 Nov; 70(21):8651-61. PubMed ID: 20959468
[TBL] [Abstract][Full Text] [Related]
6. The immunomodulator FTY720 has a direct cytoprotective effect in oligodendrocyte progenitors.
Coelho RP; Payne SG; Bittman R; Spiegel S; Sato-Bigbee C
J Pharmacol Exp Ther; 2007 Nov; 323(2):626-35. PubMed ID: 17726159
[TBL] [Abstract][Full Text] [Related]
7. FTY720 analogues as sphingosine kinase 1 inhibitors: enzyme inhibition kinetics, allosterism, proteasomal degradation, and actin rearrangement in MCF-7 breast cancer cells.
Lim KG; Tonelli F; Li Z; Lu X; Bittman R; Pyne S; Pyne NJ
J Biol Chem; 2011 May; 286(21):18633-40. PubMed ID: 21464128
[TBL] [Abstract][Full Text] [Related]
8. Immunology. The sources of a lipid conundrum.
Chun J
Science; 2007 Apr; 316(5822):208-10. PubMed ID: 17431159
[No Abstract] [Full Text] [Related]
9. FTY720 (fingolimod) increases vascular tone and blood pressure in spontaneously hypertensive rats via inhibition of sphingosine kinase.
Spijkers LJ; Alewijnse AE; Peters SL
Br J Pharmacol; 2012 Jun; 166(4):1411-8. PubMed ID: 22251137
[TBL] [Abstract][Full Text] [Related]
10. Sphingosine kinase type 2 is essential for lymphopenia induced by the immunomodulatory drug FTY720.
Zemann B; Kinzel B; Müller M; Reuschel R; Mechtcheriakova D; Urtz N; Bornancin F; Baumruker T; Billich A
Blood; 2006 Feb; 107(4):1454-8. PubMed ID: 16223773
[TBL] [Abstract][Full Text] [Related]
11. Fingolimod (FTY720): a recently approved multiple sclerosis drug based on a fungal secondary metabolite.
Strader CR; Pearce CJ; Oberlies NH
J Nat Prod; 2011 Apr; 74(4):900-7. PubMed ID: 21456524
[TBL] [Abstract][Full Text] [Related]
12. The immunomodulator FTY720 is phosphorylated and released from platelets.
Anada Y; Igarashi Y; Kihara A
Eur J Pharmacol; 2007 Jul; 568(1-3):106-11. PubMed ID: 17553484
[TBL] [Abstract][Full Text] [Related]
13. Essential requirement for sphingosine kinase 2 in a sphingolipid apoptosis pathway activated by FTY720 analogues.
Don AS; Martinez-Lamenca C; Webb WR; Proia RL; Roberts E; Rosen H
J Biol Chem; 2007 May; 282(21):15833-42. PubMed ID: 17400555
[TBL] [Abstract][Full Text] [Related]
14. The immunosuppressant FTY720 is phosphorylated by sphingosine kinase type 2.
Paugh SW; Payne SG; Barbour SE; Milstien S; Spiegel S
FEBS Lett; 2003 Nov; 554(1-2):189-93. PubMed ID: 14596938
[TBL] [Abstract][Full Text] [Related]
15. Effects of phosphorylation of immunomodulatory agent FTY720 (fingolimod) on antiproliferative activity against breast and colon cancer cells.
Nagaoka Y; Otsuki K; Fujita T; Uesato S
Biol Pharm Bull; 2008 Jun; 31(6):1177-81. PubMed ID: 18520051
[TBL] [Abstract][Full Text] [Related]
16. A photoreactive analogue of the immunosuppressant FTY720.
Sun C; Bittman R
J Org Chem; 2006 Mar; 71(5):2200-2. PubMed ID: 16497020
[TBL] [Abstract][Full Text] [Related]
17. FTY720 Inhibits Tumor Necrosis Factor-alpha-Induced Proliferation and Extracellular Signal-Regulated Kinase Phosphorylation of Human Smooth Muscle Cells.
Böhler T; Kamar N; Etienne L; Galvani S; Canivet C; Thomsen M; Salvayre R; Nègre-Salvayre A; Rostaing L; Auge N
Transplant Proc; 2009 Mar; 41(2):705-6. PubMed ID: 19328962
[TBL] [Abstract][Full Text] [Related]
18. Understanding the effects of FTY720 on leukocyte trafficking.
Racke MK
Arch Neurol; 2010 Dec; 67(12):1433-4. PubMed ID: 21149807
[No Abstract] [Full Text] [Related]
19. FTY720: from bench to bedside.
Kahan BD
Transplant Proc; 2004 Mar; 36(2 Suppl):531S-543S. PubMed ID: 15041402
[TBL] [Abstract][Full Text] [Related]
20. Effect of FTY720 on apoptosis of smooth muscle cells.
Böhler T; Guillebaud J; Etienne L; Canivet C; Kamar N; Rostaing L; Thiers JC; Galvani S; Augé N; Salvayre R; Nègre-Salvayre A; Thomsen M
Transplant Proc; 2007 Oct; 39(8):2624-6. PubMed ID: 17954194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
